HCPCS Level IIdrugActive
J9302
Ofatumumab injection
BETOS: O1D
Effective: 2011-01-01
Description
Injection, ofatumumab, 10 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Arzerra
Manufacturer
Novartis Pharmaceuticals Corporation
HCPCS Dosage
10 MG
Billing Units
10.0000
2
NDC Products
opps
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.